OCIAD1 antibody

GeneTex

OCIAD1 antibody

9

WB: 1 - 2 microg/mL. ICC/IF: 20 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

OCIAD1

OCIA domain containing 1

ASRIJ; OCIA; OCIA domain-containing protein 1; ovarian cancer immunoreactive antigen domain containing 1; ovarian cancer immunoreactive antigen domain containing 1A; ovarian carcinoma immunoreactive antigen; TPA018

Rabbit

IgG

OCIA domain-containing protein 1

OCIAD1 was identified via immunoscreening of an ovarian carcinoma cDNA library from ovarian cancer patients and is expressed in multiple tissues including ovary, placenta, brain, testis, prostate, and mammary gland. Two isoforms of OCIAD1 are known to exist; the shorter isoform is restricted to the central nervous system. OCIAD1 is a transmembrane protein whose overexpression in HEY ovarian cancer cells increased lysophosphatidic acid- (LPA-)induced, but not basal level cell adhesion to extracellular matrix proteins collagen I and laminin10/11. This adhesion is not blocked by LY294002 and GF109203X, suggesting that OCIAD1 does not use protein kinase C and PI3 kinase signaling pathways to exert its effect on adhesion.

-20°C or -80°C,2°C to 8°C

12352203